Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of Xofluza Treatment of Influenza in Pediatric Transplant Recipients, Waitlisted Subjects and Household Members After Early Infection Alerting Using Wearable Devices

NCT06161454 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.

NCT NCT06161454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06161454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of Xofluza Treatment of Influenza in Pediatric Transplant Recipients, Waitlisted Subjects and Household Members After Early Infection Alerting Using Wearable Devices
Lead sponsor
Children's Hospital of Philadelphia
Phase
Phase 4
Overall status
Completed
Start date
December 14, 2023
Completion date
April 30, 2025
Enrollment
498 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection viral, infection, coronavirus, infections, influenza, transplant